Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2 Seroprevalence in Grand Nancy (COVAL-NANCY)
NCT04448769Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Prevalence of positive anti-SARS-CoV-2 IgT (IgM/IgA/IgG) serologies at Day 1. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04448769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448769.